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High dose rate brachytherapy (HDRB) is an established
technique for the treatment of skin tumours in human
medicine. Squamous cell carcinomas and basal cell
carcinomas respond especially well, with 96–98% cure rates
and excellent cosmetic outcomes, which compares
extremely favourably to surgery for these patients (Delishaj
et al., 2016; Skowronek, 2015; Tagliaferri et al., 2021). Indeed,
in human non-malignant skin cancer, HDRB is often the
treatment of choice for lesions that cannot be surgically
removed without serious defects, which require cosmetic
and/or reconstructive procedures (Delishaj et al., 2016;
Skowronek, 2015). Compared to external beam radiotherapy
(EBRT), brachytherapy has favourable dose distribution, with
improved tumour radiation coverage and better protection
of the surrounding normal organs and tissues at risk of
secondary radiation damage due to the rapid dose fall-off. It,
therefore, has a lower complication rate than EBRT, making it
an attractive option (Delishaj et al., 2016). The ability to treat
large tumours with minimal detrimental effects to the
surrounding normal tissues and a high probability of cure with
HDRB makes it an interesting option for equine skin tumours.
Interstitial brachytherapy is theoretically the ideal technique
for radiation treatment of equine tumours because a high
radiation dose can be delivered precisely and safely to the
tumour in a relatively short time (Theon, 1998).
The technique is relatively simple; interstitial catheters or
needles are placed into the tumour at equally spaced
intervals and using a remote afterloader, HDRB is delivered to
the tumour without the need for any operator exposure,
rendering it much safer and more practical than traditional
low dose rate brachytherapy techniques (Hollis, 2017). In
humans, CT imaging is performed as the standard once the
applicators are in situ to allow for accurate treatment
planning. However, in horses, this is unlikely to be possible,
financially viable or practical in the vast majority of cases. A
technique of orthogonal radiography has been developed to
allow for accurate 3D planning for the treatment of
periocular tumours in horses using a commercially available
brachytherapy planning system (Hollis & Berlato, 2017b), but
computer-assisted planning following catheter or needle
placement is also possible using orthogonal photographs as
described (Conti et al., 2021) or via hand planning methods,
although this will have reduced accuracy compared to
computer-assisted methods. This may be more appropriate in
locations where the underlying tissues are less radiosensitive;
the cornea is far more radiosensitive than bone (Hollis, 2017),
so the accuracy of dose distribution is more critical in
periocular locations compared to treatments over the distal
limb.
HDRB has been briefly described for the treatment of
equine skin tumours (Theon, 1998) and two small case series of
its use in the treatment of equine sarcoids with a reasonable
length of follow-up have been published (Hollis & Berlato,
2017a, b). The author has also used HDRB in horses with good
success rates in over 140 sarcoids and squamous cell
carcinomas (A. Hollis, unpublished data 2021). A variety of
other tumours in dogs have been treated with HDRB, including
carcinomas, various sarcomas, mast cell tumours, lymphoma
and melanoma (Watkins, 2019). However, to the author’s
knowledge, there is only one report of HDRB for the treatment
of dermal hamartomas in any veterinary species (Conti et al.,
2021). Interestingly, in humans, hamartomas in various
locations have been successfully treated with different
forms of radiotherapy including radiosurgery, stereotactic
brachytherapy and HDRB (Mittal et al., 2013; Romanelli, 2018).
In the majority of veterinary reports of hamartomas, including
those in horses, surgery was performed as the treatment of
choice (Corzo-Menendez et al., 2001; Gualtieri et al., 2009;
Nolf et al., 2014; Prudic et al., 2020; Saifzadeh et al., 2006;
Sanders et al., 2002). However, in the case of recurrent lesions
or those in which surgical excision is not possible due to their
location, HDRB appears to be a safe and successful method
of treatment, where this technique is available.
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